Success in Leukemia treatment trials

Israel’s BiolineRx has reported positive results from Phase II trials of its BL-8040 treatment in relapsed or refractory acute myeloid leukemia (r/r AML). It had a triple positive effect on the leukemic cells only two days after a single cycle of therapy.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *